Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Hair loss needs more research for better treatments.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Overweight women with PCOS are more likely to have excess male hormones.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Minoxidil works faster, but ketoconazole is a safer alternative for female hair loss.

The document concludes that accurate diagnosis and understanding the type of hair disorder are crucial for treating hair loss in children.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.